🔗 Share this article

Chancellor Reeves has announced she is preparing "specific steps to address cost of living issues" in next month's financial statement.

Speaking to media outlets, she emphasized that reducing inflation is a collective duty of both the administration and the Bank of England.

The United Kingdom's inflation rate is forecast to be the most elevated among the Group of Seven developed nations this year and next.

Potential Utility Bill Measures

Reports indicate the government could take action to bring down utility costs, for example by slashing the current 5% rate of VAT applied on energy supplies.

Another possibility is to reduce some of the government charges currently added to household expenses.

Budgetary Constraints and Expert Predictions

The administration will receive the latest report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much scope there is for these actions.

The view from the majority of experts is that the Chancellor will have to declare tax increases or expenditure reductions in order to fulfill her declared borrowing rules.

Earlier on the same day, calculations suggested there was a £22bn gap for the Treasury chief to fill, which is at the lower end of forecasts.

"There's a joint task between the Bank of England and the administration to continue tackling some of the causes of price increases," the Chancellor informed reporters in the US capital, at the annual meetings of the IMF and global financial institution.

Tax Commitments and International Issues

While a great deal of the attention has been on likely tax rises, the Treasury chief said the most recent data from the OBR had not altered her pledge to election pledges not to increase rates on income tax, sales tax or National Insurance.

She blamed an "uncertain global environment" with increasing international and trade concerns for the fiscal tax moves, probably to be targeted on those "wealthiest."

Global Economic Disputes

Referring to apprehensions about the United Kingdom's trade ties with China she said: "The UK's security interests invariably are paramount."

Last week's statement by China to tighten export controls on rare earths and other materials that are key for high-technology manufacturing led American leader Donald Trump to threaten an extra 100% import tax on imports from China, raising the possibility of an full-scale commercial conflict between the two economic giants.

The US Treasury Secretary described China's action "commercial pressure" and "a global supply chain power grab."

Inquired about accepting the American proposal to join its dispute with the Asian nation, the Chancellor said she was "extremely troubled" by Chinese actions and encouraged the Chinese government "not to put up barriers and restrict access."

She said the decision was "damaging for the world economy and causes further headwinds."

"I believe there are areas where we need to address China, but there are also important chances to export to Chinese markets, including banking sector and other sectors of the economy. We've got to maintain that equilibrium correct."

The chancellor also confirmed she was working with G7 counterparts "on our own critical minerals approach, so that we are reduced dependence."

Health Service Drug Costs and Investment

The Chancellor also recognized that the cost the NHS spends on drugs could increase as a consequence of current discussions with the US government and its pharmaceutical firms, in exchange for reduced taxes and funding.

A number of the world's largest drug companies have said recently that they are either halting or canceling operations in the UK, with some blaming the modest returns they are obtaining.

Recently, the Science Minister said the price the NHS spends on medicines would must increase to prevent businesses and drug research funding departing from the United Kingdom.

Reeves informed the BBC: "We have seen due to the payment system, that clinical trials, innovative medicines have not been offered in the United Kingdom in the way that they are in other EU nations."

"The objective is to guarantee that individuals receiving treatment from the NHS are can obtain the finest critical medicines in the world. And so we are looking at this situation, and... looking to obtain increased funding into Britain."